Tech Company Financing Transactions
Sensate Funding Round
Incisive Ventures, 37 Angels and Dangerous Ventures participated in a $3.2 million Seed funding round for Sensate. The round was announced by the company on 3/16/2023.
Transaction Overview
Company Name
Announced On
3/16/2023
Transaction Type
Venture Equity
Amount
$3,200,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations, users and its business reach.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Winchester House Deane Gate Avenue
Taunton, England, TA1 2UH
UK
Taunton, England, TA1 2UH
UK
Phone
Undisclosed
Email Address
Overview
Bioself is the innovator and IP holder of the powerful, stress-reducing consumer system, Sensate, which uses a unique Patent Pending process to calm the fight-flight-freeze response and improve HRV (Heart Rate Variability) in an enjoyable and engaging way. This very simply and accessibly soothes stress instantly and without the need for skill or effort.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anna Gudmundson
Chief Financial Officer
Chris Park
Chief Scientific Officer
Stefan Chmelik
Browse more venture capital transactions:
Prev: 3/16/2023: Doroni Aerospace venture capital transaction
Next: 3/16/2023: Allermi venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs